These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

210 related articles for article (PubMed ID: 16875575)

  • 1. [Id4 gene methylation for detection of minimal residual disease in acute leukemia].
    Zhao Y; Yu L; Wang QS; Li HH; Bo J; Wang SH; Jin HJ; Lou FD
    Zhonghua Xue Ye Xue Za Zhi; 2006 May; 27(5):298-301. PubMed ID: 16875575
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Significance of id4 promoter methylation in monitoring AML patients with completely remission].
    Zhao Y; Wang QS; Li HH; Bo J; Dou LP; Jing Y; Wang SH; Yu L
    Zhongguo Shi Yan Xue Ye Xue Za Zhi; 2008 Jun; 16(3):476-8. PubMed ID: 18549611
    [TBL] [Abstract][Full Text] [Related]  

  • 3. ID4 methylation predicts high risk of leukemic transformation in patients with myelodysplastic syndrome.
    Wang H; Wang XQ; Xu XP; Lin GW
    Leuk Res; 2010 May; 34(5):598-604. PubMed ID: 19853913
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Investigation on MS-PCR as a method for detecting minimal residual disease in acute leukemia].
    Zhao Y; Li HH; Bo J; Jing Y; Wang SH; Wang QS; Dou LP; Sun JF; Yu L
    Zhongguo Shi Yan Xue Ye Xue Za Zhi; 2009 Apr; 17(2):455-8. PubMed ID: 19379587
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Methylation of Id4 gene promoter in acute leukemia].
    Zhao Y; Wang QS; Dou LP; Bo J; Li HH; Jing Y; Yu L
    Zhongguo Shi Yan Xue Ye Xue Za Zhi; 2007 Dec; 15(6):1156-60. PubMed ID: 18088456
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [ID4 promoter methylation in acute myeloid leukemia].
    Xu RR; Liu F; Cui X; Zhang XW; Wang Y
    Zhongguo Shi Yan Xue Ye Xue Za Zhi; 2011 Jun; 19(3):582-4. PubMed ID: 21729527
    [TBL] [Abstract][Full Text] [Related]  

  • 7. DNA methylation of tumor suppressor genes in clinical remission predicts the relapse risk in acute myeloid leukemia.
    Agrawal S; Unterberg M; Koschmieder S; zur Stadt U; Brunnberg U; Verbeek W; Büchner T; Berdel WE; Serve H; Müller-Tidow C
    Cancer Res; 2007 Feb; 67(3):1370-7. PubMed ID: 17283175
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Study on the methylation of p15 gene CpG islands in acute leukemia: using methylation-specific PCR method].
    Zhang Y; Lou F; Yu L
    Zhonghua Xue Ye Xue Za Zhi; 1999 Dec; 20(12):628-30. PubMed ID: 11721363
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Detection of minimal residual disease in acute leukemia patients.
    van Dongen JJ; Szczepański T; de Bruijn MA; van den Beemd MW; de Bruin-Versteeg S; Wijkhuijs JM; Tibbe GJ; van Gastel-Mol EJ; Groeneveld K; Hooijkaas H
    Cytokines Mol Ther; 1996 Jun; 2(2):121-33. PubMed ID: 9384697
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [The significance of DNA-binding inhibitor 4 promoter methylation status in acute leukemia].
    Zhao Y; Yu L; Wang QS; Li HH; Bo J; Dou LP
    Zhonghua Nei Ke Za Zhi; 2006 Jul; 45(7):576-8. PubMed ID: 17074115
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Quantitative assessment of WT1 gene expression after allogeneic stem cell transplantation is a useful tool for monitoring minimal residual disease in acute myeloid leukemia.
    Candoni A; Tiribelli M; Toffoletti E; Cilloni D; Chiarvesio A; Michelutti A; Simeone E; Pipan C; Saglio G; Fanin R
    Eur J Haematol; 2009 Jan; 82(1):61-8. PubMed ID: 18801058
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Methylation of p15 and p16 genes in adult acute leukemia: lack of prognostic significance.
    Chim CS; Tam CY; Liang R; Kwong YL
    Cancer; 2001 Jun; 91(12):2222-9. PubMed ID: 11413509
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Study on the correlation between Chinese medical syndrome types and ID4 gene promoter methylation in human acute myeloid leukemia].
    Liu F; Xu RR
    Zhongguo Zhong Xi Yi Jie He Za Zhi; 2012 Apr; 32(4):471-3. PubMed ID: 22803425
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Clinical significance of ID4 methylation detection by quantitative methylation-specific PCR in acute leukemia].
    Liu Y; Zhong WW; Kang HY; Wang LL; Lu XC; Yu L; Zhu HL
    Zhongguo Shi Yan Xue Ye Xue Za Zhi; 2014 Jun; 22(3):675-80. PubMed ID: 24989275
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Epigenetic inactivation of INK4/CDK/RB cell cycle pathway in acute leukemias.
    Chim CS; Wong AS; Kwong YL
    Ann Hematol; 2003 Dec; 82(12):738-42. PubMed ID: 14513284
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Detection and treatment of molecular relapse in acute myeloid leukemia with RUNX1 (AML1), CBFB, or MLL gene translocations: frequent quantitative monitoring of molecular markers in different compartments and correlation with WT1 gene expression.
    Doubek M; Palasek I; Pospisil Z; Borsky M; Klabusay M; Brychtova Y; Jurcek T; Jeziskova I; Krejci M; Dvorakova D; Mayer J
    Exp Hematol; 2009 Jun; 37(6):659-72. PubMed ID: 19463768
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Wilms tumour gene 1 overexpression in bone marrow as a marker for minimal residual disease in acute myeloid leukaemia.
    Hämäläinen MM; Kairisto V; Juvonen V; Johansson J; Aurén J; Kohonen K; Remes K; Salmi TT; Helenius H; Pelliniemi TT
    Eur J Haematol; 2008 Mar; 80(3):201-7. PubMed ID: 18081724
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Preliminary study on Id4 as a reporter for all patients before relapse].
    Zhao Y; Li HH; Dou LP; Jing Y; Wang QS; Yu L
    Zhongguo Shi Yan Xue Ye Xue Za Zhi; 2008 Oct; 16(5):990-2. PubMed ID: 18928580
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Minimal residual disease detection in acute myeloid leukemia by mutant nucleophosmin (NPM1): comparison with WT1 gene expression.
    Barragan E; Pajuelo JC; Ballester S; Fuster O; Cervera J; Moscardo F; Senent L; Such E; Sanz MA; Bolufer P
    Clin Chim Acta; 2008 Sep; 395(1-2):120-3. PubMed ID: 18590714
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Detecting methylation of the calcitonin gene in monitoring treatment and disease evolution for myelogenous leukemia].
    Xie XH; Chen ZZ; Zhang XM; Huang MQ
    Ai Zheng; 2003 Jun; 22(6):616-9. PubMed ID: 12948412
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.